학술논문
CO154 Ramucirumab+Docetaxel Post Immune Checkpoint Inhibitors (ICIS) and Platinum-Based Chemotherapy (CHEMO) in Advanced or Metastatic Non-Small Cell Lung Cancer (ANSCLC): Learnings from the Treat-Lung Observational Study
Document Type
Abstract
Author
Source
In Value in Health July 2022 25(7) Supplement:S333-S333
Subject
Language
ISSN
1098-3015